Associated Papers
Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: A nationwide CEREO study.
Groh M et al.
American Journal of Hematology, 2024
GATA1 mutation analysis and molecular landscape characterization in acute myeloid leukemia with trisomy 21 in pediatric patients.
Panferova A et al.
International Journal of Laboratory Hematology, 2021
JAK1 somatic mutation in a myeloproliferative neoplasm.
Arulogun SO et al.
Haematologica, 2017
Regulation of JAK2 activation by Janus homology 2: evidence from molecular dynamics simulations.
Wan S et al.
Journal of Chemical Information and Modeling, 2012
Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitors.
Hornakova T et al.
Haematologica, 2011
Transforming JAK1 mutations exhibit differential signalling, FERM domain requirements and growth responses to interferon-γ.
Gordon GM et al.
The Biochemical Journal, 2010
Select a paper to view details